%PDF-1.5
%
59 0 obj
<>
endobj
61 0 obj
<>stream
2016-06-16T16:15:21-05:00
QuarkXPress(R) 9.3
2024-03-29T00:45:32-07:00
2024-03-29T00:45:32-07:00
QuarkXPress(R) 9.3
application/pdf
An Open-label, Phase II Study of the Safety and Tolerability of Pirfenidone in Patients with Scleroderma-associated Interstitial Lung Disease: the LOTUSS Trial
%%DocumentProcessColors: Black
%%EndComments
uuid:a89ced10-1dd1-11b2-0a00-5a08275d6100
uuid:a89ced15-1dd1-11b2-0a00-aa0000000000
endstream
endobj
19 0 obj
<>]>>
endobj
49 0 obj
<>
endobj
48 0 obj
<>
endobj
56 0 obj
<>
endobj
57 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0 0 585 783]/Type/Page/u2pMat[1 0 0 -1 0 783]/xb1 0/xb2 585/xt1 0/xt2 585/yb1 0/yb2 783/yt1 0/yt2 783>>
endobj
58 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/TrimBox[0 0 585 783]/Type/Page/u2pMat[1 0 0 -1 0 783]/xb1 0/xb2 585/xt1 0/xt2 585/yb1 0/yb2 783/yt1 0/yt2 783>>
endobj
68 0 obj
[73 0 R]
endobj
69 0 obj
<>stream
HW]o:}pۤnaG!ǟ7(0t7o".7
5G>5Gbp
헗'jݗ<wc.r-ZL3ͮb%fh-7|εl9L7Xa5A'-1|>.s}hyx4_1;֒ e*ЕEK~x-,@
y2ڋeC j
}m)ܼ½"eb\4䣎ѐxtAvsNտr|&!Er}v`?Z%%+;&,ncZs֪1B$<ǞUYY
!CALs"AnYp%]=HE`"UZDKH4tZO.nf.JY>=@srPĬUuR:Bp=U$7Nr"ח&}BN>0x|5;VfRq;,GsTUY;%|qkߴQ4,=p3zm4-/P5l$CXso :G=NL(|$$f'*9ؔy+.IV)jcW_q nAԐMH
t\ 媷CI[/bJJ]\zT_K5.ϖ8RW'yp;gV)F'%;3caٻפ#8ж(EH0v ;[2VxslMf[!gK"*Y9/BTfS,Ttx)$Ľr-d3cΩ_Xc58}lCDACOn%_M\RVJ}p@LTE)
Jd{CA
8h{̵{`5mܕV)ρJnh
bbQ@
F"`G;sMtTsH^58=3zCSNdPw9Rfxɻlޣ;AF |IY0W{sra`8hi8Z݂pX
7E%$K~AB5h Wftj%omz0y!p2aY *yD;^Aޮ%U
L[3]w^;kw!5/e.~ULN@LQ`P6R}!D/dA(EP,Ɛw"T }+? g`YxIQ0,t
[搴T0k>0;ҕ06Y,ycb9ͻhvD9WSDE]+6@UxKnذյ,ҳL0z6Ua1ͻ~cCo; d=5-,kOܓ^ Ƿ,CUn<B&';Kʓ_j,S!*yG{Sh+S]4Fñz5^n/x'4?I/]䮼&qD\hQu
#f)C
Rp`v7z>t( vtsјtl2ʠ">I5:$WV]#~vqG"O}ts]HX[k!䓖
DJ~*rK6296 ^;'vK,l||d\?H1ϩn ;hQPf2λ4#lZ⢅|\'R2$ŕjC毽bH2qf4*pZ] :3wu4jW&mӨ
wh|.9$d,<^+^+*Gm
6YՄzkT\3F͓Y+pj_P\bDč.᪥S25up;1QKlcFw^V"{@@n1&7+qofZ ^1~.R%r~'u]ѠK!ɢгhaH=ro:Ϡ __-W(x3HIYRz6RyGU`9˪T@5Ip{^ﳐX}wq@? Ѱv`%7\pJrSsh4} Բ_ႮcrId^J3WO`t59$( :g_q9]yhQ:w<>&~!Sޜf #7~A,NPc1FʦU4QoXg3ֆqTW.))v{5QR)xH߽yXR)Y)l7u@D6/Fs2*dmī B~+Fr-RZHAөsy 8NJrbo8F-2Ć= FEc'ɝ$j.hPNHfo1'ҺtQ6S,DiIEfp)5|~[H8Ouw)|4vk5!vjo|nfa
pzcBljy'KWA[Eax\%AD}]c1n`ta8R]DO\vKgJǑ诸ܲ5EQ)Z-BA[QG̱Nu? 2| PvWad-0/KBrLOK,FP5FKJ'~` w$b`k9 8s;6GnDD^/T\Ά 5%1N?ڝ3b*0,gs+Fsȏ67/zLKP?ˢ>p`~KX6\Ì8jN/˹~RSx9Gb3A{AnŨUiպ"%NßG5=QW}߷g*-M+6KɮN\Qk}C*[1/+ɵ$%Dn3fo?{ >veqP ?|ۑXQ[lufru
;)r "ÎqȺ*B2;ƂQڥC Tg31
0
0[Q-V3uIc!|zHuo ^ZNor>XշW,áBLo]#0
B@K8%;a}0J*CΔ!E,݊QnDs`b/+1R9colcn9.XcsQ~/qt%PH
FGv;YH"C"O">~11d.K>cƒD]Zf|,}f6W:~\t+_oI%
K|lp4%:tū[+#(1/| X==LFWDei+֗:1:>
#F1pSe1DAC;p-WX @EwxV!&8U\ZolkPw <]}F
aƹlIxYSIgIP&^k7aE+L/-WdV~+O/=jCH瑳틽c/fT6D{ZM2TlC{wz6[;u&U!^A&jaeC$*Np옧93;_BT=/oYƪCQ"-O7.krcq?}xqho#L"Sq*qYO2;/g1.%Wqx.Zîm%ϵ5X
q+ݿHտsdӜyHsP=X8m#:Jpj,?|c#ްkZq0R7eUlQ.p/*huP7<Q8Xi;d'yK|ĥo,M"E;h MlTUja]LwPv?^
eww0EV*iA#Qg㺸i%u P ) ]x
JhdQzߙ6G ~=EڍU TCf/dX%KIʋ~ʉՙ`AxJ>l};e~>]`e^{Ejxb1#mRtZ)}{iq"bH+\xNbB;V
YXޔf-
[Qnܔs'\[MR4GxyKW ?nәK
0%I3;yoll{@t?tC$_bGHj;2 |RR3iqx'k8/@c{#yYiÕLjݢ֦AoP VV$p2w1B2b7CܭP=7q$2S҅ՠYan\Y#$ٞkeβөzWjXɆY=)b!Ay Q. lfXlD`9$uQS)H\_{V"9Y2"2*F~$Hl!;d,)ʑgYB=ւMXzeDT0
۠rMV;kQcˏAt_,0pͅ'cM2ry:ӻ\fU~Sq!մl;$wqj"换ļI!VԤ@trPˬ2^9`\C<ɄU'Ӟ,E?cK+b> A_1VuvObIϣ*VyMShNÑY#QDiFǪ4:z
++JJska,@Y/
)Т1Am
ړzLEQ^QGq $P:݉(Bzf> |8ΜhV9ϊzFa4, qe'
"glhJH5d^Ŕ;bjY_6))0(BBAg*rJ]0q=R_(BL.w).F6V͘K;m
ʣcI/zfB~YjJFF=h]QG]L ]O̵Rӄ5Kz3iCU3A;CT`(,~35tl8А3¨dC6d,-~a~h6QjȪYU P6x*OHUgdĖæzW3w>ʙ1^iB,j !!^*kW̆ވXS/UsυĠߎbtPYRLΙȴ7ԣ0*[1!1=J2;ٺ
{kZ)/Cr,դ'vb݆ޡuξΨ^xk26.lb*ˠ{
%&%/CAiQid4JHt^mm@]_&ij51M